Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (111-120 of 668) with videos related to

Pageof 67
Sort By:
Alimentary Pharmacology & Therapeutics|August 22, 2022
Editorial: slow progress to optimising H. pylori eradication treatment with antisecretory drugsJavier P Gisbert, Richard H Hunt
Medicina Clinica|May 2, 2003
[Cyclooxygenase-2 and gastroduodenal lesions. Any relationship with Helicobacter pylori ? A systematic review]Javier P Gisbert, José María Pajares
European Journal of Internal Medicine|September 7, 2010
Treatment of Helicobacter pylori infection: the past and the futureJavier P Gisbert, José María Pajares
Helicobacter|July 24, 2004
Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic reviewJavier P Gisbert, José María Pajares
Lancet (London, England)|April 30, 2013
Quadruple therapy for Helicobacter pylori infectionJavier Molina-Infante, Javier P Gisbert
The American Journal of Gastroenterology|November 8, 2017
Research to the N-Power: The Strengths of Networked Clinical Collaboration in SpainAdrian G McNicholl, Javier P Gisbert
World Journal of Gastroenterology|August 19, 2014
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistanceJavier Molina-Infante, Javier P Gisbert
Evidence-Based Medicine|July 9, 2016
In H. pylori- infected patients second-line treatment with sequential levofloxacin therapy was more effective than levofloxacin triple therapy but was still suboptimalAdrian G McNicholl, Javier P Gisbert
Alimentary Pharmacology & Therapeutics|July 15, 2025
Editorial: H. pylori Treatment-Old Ingredients in New Effective Regimens. Authors' ReplyOlga P Nyssen, Javier P Gisbert
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2022
ReplyOlga P Nyssen, Javier P Gisbert
Pageof 67

Showing results (111-120 of 668) with videos related to

Sort By:
Pageof 67
Alimentary Pharmacology & Therapeutics|August 22, 2022
Editorial: slow progress to optimising H. pylori eradication treatment with antisecretory drugsJavier P Gisbert, Richard H Hunt
Medicina Clinica|May 2, 2003
[Cyclooxygenase-2 and gastroduodenal lesions. Any relationship with Helicobacter pylori ? A systematic review]Javier P Gisbert, José María Pajares
European Journal of Internal Medicine|September 7, 2010
Treatment of Helicobacter pylori infection: the past and the futureJavier P Gisbert, José María Pajares
Helicobacter|July 24, 2004
Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic reviewJavier P Gisbert, José María Pajares
Lancet (London, England)|April 30, 2013
Quadruple therapy for Helicobacter pylori infectionJavier Molina-Infante, Javier P Gisbert
The American Journal of Gastroenterology|November 8, 2017
Research to the N-Power: The Strengths of Networked Clinical Collaboration in SpainAdrian G McNicholl, Javier P Gisbert
World Journal of Gastroenterology|August 19, 2014
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistanceJavier Molina-Infante, Javier P Gisbert
Evidence-Based Medicine|July 9, 2016
In H. pylori- infected patients second-line treatment with sequential levofloxacin therapy was more effective than levofloxacin triple therapy but was still suboptimalAdrian G McNicholl, Javier P Gisbert
Alimentary Pharmacology & Therapeutics|July 15, 2025
Editorial: H. pylori Treatment-Old Ingredients in New Effective Regimens. Authors' ReplyOlga P Nyssen, Javier P Gisbert
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2022
ReplyOlga P Nyssen, Javier P Gisbert
Pageof 67